These stimulate the release of GLP-1 [1,3,4]
Semaglutide is a GLP-1 receptor agonist used to: Manage type 2 diabetes Support significant, clinically supervised weight loss Improve glycemic control by stimulating insulin and reducing appetite Available under brands like Ozempic (injectable) and Rybelsus (oral), Semaglutide helps patients reduce A1C levels, improve metabolic health, and lose weightoften when other therapies have failed
May lower blood sugar levels, so adjustment of diabetes medications might be necessary
Case Presentation A 64-year-old female with hyperlipidemia and class 1 obesity (height 167.6 cm, weight 86.2 kg, body mass index 30.67 kg/m 2 ) presented to the emergency department with sudden onset epigastric abdominal pain, diaphoresis, diarrhea, and chills for the past 7 hours